Vitalhub offers mission-critical healthcare software, boasting 94% YoY revenue growth and strong customer retention. See why ...

Tuesday, November 18, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft ...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy ...

Stephens Annual Investment Conference 2025 November 18, 2025 2:00 PM ESTCompany ParticipantsJohn Gallagher - SVP, Principal ...

Chara’s technology offers comparable performance to rare-earth magnet motors while delivering higher efficiency over ...

Brisbane-based enterprise software provider TechnologyOne has announced its financial results for the year ended 30 September ...

Milestone Forecasted for April or May 2026, Will Mark an Exceptional AchievementDetroit, Michigan--(Newsfile Corp. - November ...

Supposedly commercial air travel is back to normal, good for anyone coming in for the Mortgage Bankers Association of St. Louis event tomorrow and Thursday’s Mortgage Bankers Association of Kansas ...

Vertiv VRT is benefiting from the accelerating adoption of artificial intelligence (AI) and the growing demand for data ...

Future Revenue Distribution -- Management projected revenue recognition patterns of 23% for Q1, 25.5% for Q2, 24.5% for Q3, and 27% for Q4, indicating seasonality weighted toward year-end.

Freenome, an early cancer detection company developing blood-based screening tests, today announced a strategic collaboration agreement with Roche to commercialize Freenome's cancer screening ...